In-vitro Diagnostics Market - By Product (Reagents & Kits, Instruments), By Test (Clinical Chemistry, Immunoassay, Hematology, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology), End-user & Forecast to 2032

Report Content

Chapter 1   Methodology & Scope

1.1    Industry coverage

1.2    Market scope & definitions

1.3    Base estimates & working

1.3.1    Data collection

1.4    Forecast parameters

1.5    COVID-19 impact analysis at global level

1.6    Data validation

1.7    Data sources

1.7.1    Primary

1.7.2    Secondary

1.7.2.1   Paid sources

1.7.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    In-vitro diagnostics industry 360⁰ synopsis, 2018 - 2032

2.1.1    Business trends

2.1.2    Product type trends

2.1.3    Test type trends

2.1.4    Application trends

2.1.5    End-user trends

2.1.6    Regional trends

Chapter 3   In-vitro Diagnostics Industry Insights

3.1    Industry landscape, 2018 – 2032

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Rising prevalence of infectious and chronic diseases worldwide

3.2.1.2   Growing adoption and rising demand for personalized medicine

3.2.1.3   Increasing adoption of point-of-care testing in developing countries

3.2.1.4   Surging number of pathology labs and services equipped with advanced diagnostics machine

3.2.2    Industry pitfalls & challenges

3.2.2.1   High cost of diagnostic services

3.2.2.2   Unfavorable reimbursement scenario

3.3    Growth potential analysis

3.3.1    By product type

3.3.2    By test type

3.3.3    By application

3.3.4    By end-user

3.4    COVID-19 impact analysis

3.5    Porter’s analysis

3.6    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.1.1    Abbott Laboratories

4.1.2    Becton, Dickinson, and Company

4.1.3    Bio-Rad Laboratories

4.2    Competitive dashboard, 2022

4.3    Company matrix analysis, 2022

4.4    Competitive analysis of major market players

4.5    Competitive positioning matrix

4.6    Strategic outlook matrix   

Chapter 5   In-vitro Diagnostics Market, By Product Type

5.1    Key segment trends

5.2    Reagents & kits

5.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.3    Instruments

5.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6   In-vitro diagnostics Market, By Test Type

6.1    Key segment trends

6.2    Clinical chemistry

6.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.3    Immunoassay/immunochemistry

6.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.4    Molecular diagnostics

6.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.5    Hematology

6.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.6    Urinalysis

6.6.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.7    Others

6.7.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7   In-vitro Diagnostics Market, By Application

7.1    Key segment trends

7.2    Oncology

7.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.3    Infectious diseases

7.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.4    Diabetes

7.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.5    Cardiology

7.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.6    Nephrology

7.6.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.7    Autoimmune diseases

7.7.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.8    Drug testing/pharmacogenomics

7.8.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.9    Others

7.9.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8   In-vitro Diagnostics Market, By End-user

8.1    Key segment trends

8.2    Hospitals

8.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

8.3    Diagnostic laboratories

8.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

8.4    Academic & research institutes

8.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

8.5    Others

8.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9   In-vitro diagnostics Market Market, By Region

9.1    Key regional trends

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Poland

9.3.7    Switzerland

9.3.8    Sweden

9.4    Asia Pacific

9.4.1    China

9.4.2    Japan

9.4.3    India

9.4.4    Australia

9.4.5    South Korea

9.4.6    Indonesia

9.4.7    Thailand

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Argentina

9.5.4    Colombia

9.5.5    Chile

9.5.6    Peru

9.6    Middle East & Africa

9.6.1    South Africa

9.6.2    Saudi Arabia

9.6.3    Kuwait

9.6.4    UAE

9.6.5    Turkey

9.6.6    Egypt

9.6.7    Israel

9.6.8    Qatar

Chapter 10   Company Profiles

10.1    Abbott Laboratories

10.2    Becton, Dickinson, and Company

10.3    bioMerieux SA

10.4    Bio-Rad Laboratories

10.5    Danaher Corporation

10.6    DiaSorin

10.7    F. Hoffmann-La Roche AG

10.8    Ortho Clinical Diagnostics (QuidelOrtho)

10.9    Siemens Healthineers

10.10    Sysmex Corporation

10.11    Thermo Fisher Scientific Inc

10.12    Qiagen